Sirinun Pisamai Tabtieang

Sirinun Pisamai Tabtieang

Auto-generated profile, based on publicly available information

Sirinun Pisamai Tabtieang

Chulalongkorn University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2020 in BMC Veterinary Research
Verified
Journal Article
Open access
PDF file
SPSekkarin Ploypetch
Sekkarin Ploypetch
SRSittiruk Roytrakul
Sittiruk Roytrakul
NPNarumon Phaonakrop
Narumon Phaonakrop
SKSuthathip Kittisenachai
Suthathip Kittisenachai
KLKantinan Leetanasaksakul
Kantinan Leetanasaksakul
GSGunnaporn Suriyaphol
Gunnaporn Suriyaphol
Background: Various types of oral tumors, either benign or malignant, are commonly found in dogs. Since saliva directly contacts the tumors and saliva collection is non-invasive, easily accessible and cost effective, salivary biomarkers are practical to be used for the diagnosis and/or prognosis of these diseases. However, there is limited knowledge of protein expression in saliva for canine oral tumors. The present study aimed to investigate novel biomarkers from the salivary proteome of dogs with early- and late-stage oral melanoma (EOM and LOM, respectively), oral squamous cell carcinoma (OSCC), benign oral tumors (BN), and periodontitis and healthy controls (CP), using an in-gel digestion coupled with mass spectrometry (GeLC-MS/MS). The relationships between protein candidates and chemotherapy drugs were explored and the expression of potential biomarkers in saliva and tissues was verified by western blot analysis. Results: For saliva samples, increased expression of protein tyrosine phosphatase non-receptor type 5 (PTPN5) was shown in all tumor groups compared with the CP group. Marked expression of PTPN5 was also observed in LOM and OSCC compared with that in BN and EOM. In addition, tumor protein p53 (p53), which appeared in the PTPN5–drug interactions, was exhibited to be expressed in all tumor groups compared with that in the CP group. For tissue samples, increased expression of p53 was shown in LOM compared with the control group. Conclusion: PTPN5 and p53 were proposed to be potential salivary biomarkers of canine oral tumors.

17 July 2024 in Animals
Verified
Journal Article
Open access
PDF file
Gotchagorn SawatphakdeeGotchagorn Sawatphakdee
Gotchagorn Sawatphakdee
JYJakarwan Yostawonkul
Jakarwan Yostawonkul
SOSaranyou Oontawee
Saranyou Oontawee
WRWatchareewan Rodprasert
Watchareewan Rodprasert
CSChenphop Sawangmake
Chenphop Sawangmake
NPNopadon Pirarat
Nopadon Pirarat
Nanostructured lipid carriers (NLC) represent the second generation of nanoparticles, offering numerous advantages over conventional delivery systems. These include improved stability, enhanced drug-loading capacity, and controlled release profiles, making them highly attractive candidates for a wide range of therapeutic applications. Their suitability for hydrophobic drugs like a traditional medicinal plant of Thailand as clove oil and alpha-mangostin. We investigated into nanostructured lipid carriers loaded with Alpha-Mangostin and clove oil (NLC-AMCO) into the physicochemical and biological characteristics to identify the formulation with the highest efficacy for treatment. The particle size, charge, polydispersity index, and other characterizations were recorded. The realtime ex vivo penetration was explored using canine gingival tissue. Drug sustained release was assessed by HPLC. Moreover, the antibacterial properties were tested by conventional methods. The NLC-AMCO can be stored at up to 40 °C for 60 days without any alterations in particle characteristics. Gingival tissue penetration and sustained drug release were superior compared to unencapsulated counterparts. It exhibited greater effectiveness in inhibiting bacterial growth than the antibiotics tested, particularly against bacteria from the oral cavities of dogs. Therefore, this alternative treatment approach offers cost-effectiveness and ease of administration for pet owners and reduces discomfort for the animals during restraint.

1 January 2023 in Veterinary Medicine International
Verified
Journal Article
Open access
PDF file
CSChanokchon Setthawongsin
Chanokchon Setthawongsin
DKDuangdaow Khunbutsri
Duangdaow Khunbutsri
SPSirinun Pisamai
Sirinun Pisamai
WRWuttinun Raksajit
Wuttinun Raksajit
SNSuchanit Ngamkala
Suchanit Ngamkala
ARAnudep Rungsipipat
Anudep Rungsipipat
Canine oral cancers have a poor prognosis and are related to chronic inflammation. This may pose a risk of secondary bacterial infection. This study aimed to compare the bacteria isolated from oral swab samples, values of C‐reactive proteins (CRPs), and clinical blood profiles of dogs with and without oral mass. A total of 36 dogs were divided in three groups: no oral mass (n = 21), oral mass (n = 8), and metastasis groups (n = 7). Significantly, both the clinical groups (the oral mass group and metastasis group) showed anemia, a decrease in the albumin‐to‐globulin ratio (AGR), and an increase in the neutrophil‐to‐lymphocyte ratio (NLR), globulin‐to‐albumin ratio (GAR), CRP, and CRP‐to‐albumin ratio (CAR) compared to the normal group. CAR showed an increasing trend in the oral mass and metastasis groups (10 times and 100 times, respectively) compared to the no oral mass group (P < 0.001). Neisseria spp. (20.78%) was the main isolated bacteria in all groups. The main genera in the no oral mass group were Neisseria spp. (28.26%), Pasteurella spp. (19.57%), and Staphylococcus spp. (19.57%). Neisseria spp., Staphylococcus spp., Klebsiella spp., and Escherichia spp. were found equally (12.5%) in the oral mass group. Escherichia spp. (26.67%), Pseudomonas spp. (13.33%), and Staphylococcus spp. (13.33%) were the main genera in the metastasis group. Interestingly, Neisseria spp. decreased in the clinical groups (Fisher’s exact = 6.39, P = 0.048), and Escherichia spp. increased in the metastasis group (Fisher’s exact = 14.00, P = 0.002). The difference of oral bacteria in clinical dogs compared to healthy dogs may be related to microbiome alterations, and both the clinical groups showed the increment of inflammatory biomarkers. This suggested that further studies should be conducted on the correlation between the specific bacteria, CRP, blood clinical parameters, and type of canine oral mass.

12 January 2023 in Veterinary World
Verified
Journal Article
Open access
NSNaparee Srisowanna
Naparee Srisowanna
CTChutimon Thanaboonnipat
Chutimon Thanaboonnipat
SPSirinun Pisamai
Sirinun Pisamai
KKKiatpichet Komin
Kiatpichet Komin
NCNan Choisunirachon
Nan Choisunirachon
Background and Aim: Ultrasound (US) is a useful tool for detecting adrenal abnormalities. However, a definite reference range differentiating normal and diseased adrenal glands in dogs of varying body sizes is still lacking. The organ dimension-to-aorta (Ao) ratio of the dogs is correlated with their body weight (BW). Therefore, this study aimed to investigate the adrenal dimensions, including adrenal pole thickness and adrenal length, as well as the adrenal dimension-to-Ao ratio, to differentiate between dogs with normal, benign lesions such as pituitary-dependent hyperadrenocorticism (PDH) and malignant invasive adrenal tumors. Materials and Methods: The medical records and US images of 39 dogs that were either normal (normal) (n = 15) or affected by PDH (n = 15) or malignant invasive adrenal tumors (tumor) (n = 9) were retrieved in this study. All the dogs had a transabdominal US on the sagittal plane. The adrenal dimensions and luminal Ao diameter at the peak of the systolic phase were recorded. The average adrenal dimensions, including the adrenal dimension-to-Ao ratio, were compared among the groups. Results: Most of the dogs in each group were small-breed dogs with comparable ages, BW, and Ao values. Both adrenal dimensions and the adrenal dimension-to-Ao ratio were significantly lower in the normal group than in the PDH and tumor groups. To differentiate the PDH group from the tumor group, adrenal dimensions of pole thickness and length were more appropriate than the adrenal dimension-to-Ao ratio. Conclusion: Adrenal dimensions and the adrenal dimension-to-Ao ratio can be used to diagnose adrenal diseases. However, in small-breed dogs, adrenal dimensions are suitable for differentiating PDH from tumor groups. Further research is required with a larger sample size and a wider range of canine body sizes.

25 April 2026 in Veterinary World
Verified
Journal Article
Open access
APAujchariyaporn Phongphuwanan
Aujchariyaporn Phongphuwanan
STSirinun Pisamai Tabtieang
Sirinun Pisamai Tabtieang
CTChutimon Thanaboonnipat
Chutimon Thanaboonnipat
TCTeerapol Chinkangsadarn
Teerapol Chinkangsadarn
TTThita Taecholan
Thita Taecholan
KSKumpanart Soontornvipart
Kumpanart Soontornvipart
Background and Aim: Obesity and osteoarthritis (OA) frequently coexist in dogs and synergistically impair mobility, muscle integrity, and quality of life (QoL). Conventional management using nonsteroidal anti-inflammatory drugs may be limited by adverse effects, particularly in overweight and geriatric patients. Bedinvetmab, a canine anti–nerve growth factor monoclonal antibody, offers targeted analgesia with a favorable safety profile. This study aimed to evaluate the effects of bedinvetmab on daily physical activity, chronic pain, and body composition in obese dogs with OA. Materials and Methods: A 56-day prospective, randomized, double-blind, placebo-controlled clinical trial was conducted in 28 client-owned obese dogs diagnosed with OA. Dogs were allocated to receive either bedinvetmab (1 mg/kg) or placebo via subcutaneous injection on Days 0 and 28. Daily activity was quantified as the mean accelerometer-derived activity count per day (MAC/day). Pain and QoL were assessed using the Canine Brief Pain Inventory. Body composition parameters included body weight, body condition score, abdominal girth, thigh girth, and estimated body fat percentage. Data were analyzed using linear mixed-effects models, repeated-measures analysis of variance, and correlation analysis, with p < 0.05 considered significant. Results: The treatment group demonstrated significant improvements in both objective and subjective outcomes. MAC/day increased significantly over time, with a 25.6% rise from baseline by Day 56 (p = 0.032). Concurrently, total pain scores decreased significantly, with a mean reduction of 1.95 points (p < 0.001). A moderate negative correlation was observed between MAC/day and pain scores (r = −0.519, p < 0.001), indicating that reduced pain was associated with increased activity. Body weight did not change significantly; however, the treatment group exhibited a significant reduction in estimated body fat percentage and preservation of thigh muscle mass compared with placebo. No adverse effects were reported. Conclusion: Bedinvetmab is a safe and effective therapeutic option for managing OA-related pain in obese dogs, leading to improved mobility and QoL. Importantly, it contributes to favorable body composition changes, particularly muscle preservation, despite minimal weight loss. These findings support its integration into multimodal OA management strategies, especially in high-risk populations where conventional therapies are limited. Keywords: accelerometer, activity monitoring, bedinvetmab, body composition, canine osteoarthritis, chronic pain, muscle preservation, obesity.

6 September 2024 in The Thai Journal of Veterinary Medicine
Verified
Journal Article
Open access
PDF file
NSNaparee Srisowanna
Naparee Srisowanna
DDDamri Darawiroj
Damri Darawiroj
NCNan Choisunirachon
Nan Choisunirachon
CTChutimon Thanaboonnipat
Chutimon Thanaboonnipat
STSirinun Pisamai Tabtieang
Sirinun Pisamai Tabtieang
Tympanic morphology of the dogs was reported to be varied due to the characteristics of the skull types. The small tympanic bulla is normally seen in brachycephalic dogs. However, this variation in narrowed-skull shaped cats has not been unveiled yet. The objective of this study was to describe the tympanic morphology of cats between brachycephalic and domestic shorthair (DSH) cats. Computer tomography (CT)-skull images of 15 domestic shorthair cats and 11 brachycephalic cats were evaluated for tympanic dimension on transverse and dorsal planes and the tympanic bone thickness. All parameters were compared between both groups. The results revealed that all tympanic parameters measured from the transverse and dorsal CT images were comparable between groups (P > 0.05) except the tympanic bone thicknesses. The result showed that the tympanic bone thickness of the brachycephalic cats was significantly thicker than that of the DSH cats (0.13 ± 0.02 vs 0.10 ± 0.01 cm, P = 0.0005). In conclusion, the present study provides information on CT tympanic morphology between the brachycephalic and DSH cats. Contrast this to the dog's information, skull type was not an effect on tympanic bullae dimension but played a major role on the tympanic bone thickness. This information could be useful during the interpretation of the tympanic bullae related lesion on the CT images.